Research dataset on the mechanism of action of Baoling Capsule in treating diabetic nephropathy based on network pharmacology analysis and experimental verification

1. Network pharmacology analysis: 5 figures (Fig. 1 to Fig. 5: Network pharmacology screening of the main active components and potential targets of BLC for treating DKD), and 2 tables (Table 1: Main active components; Table 2: Binding energies of key active components of BLC and core target molecules for docking). 2. Animal experiments: Statistical analysis of the original data in the form of column charts (Fig. 6: The effects of BLC on FBG and renal function indicators in DKD rats, Figure 8: The effects of BLC on cell apoptosis and inflammatory response in DKD rats), histopathological staining (Fig. 7: HE, PAS; Figure 8: TUNEL, IL-1β and TNF-α staining), original banding diagrams of WB (Figure 9: Protein bands of the PI3K/Akt pathway). 3. Clinical research: Original data bar charts (Fig.10-12: clinical efficacy, blood glucose, renal function, inflammatory indicators), original Western blot images (Fig.13: PI3K/Akt pathway and apoptosis-related protein bands).